The global cell culture vessels market size was estimated to be USD 4.38 billion in 2023 and is expected to reach USD 20.09 billion by 2034 with a CAGR of 14.86% during the forecast period 2024-2034. Increased biopharmaceutical research and development, advancements in cell culture technologies, rising need for vaccine production, increased stem cell and regenerative medicine research, and growing adoption of single-use technologies will all fuel market expansion.
Governments and private sectors are significantly increasing investments in life sciences research, including cell and molecular biology, driving the growing demand for cell culture vessels. For instance, the Novo Nordisk Foundation, in September 2023, committed approximately USD 141.29 million to establish a state-of-the-art facility dedicated to developing and scaling cell therapies. This facility aims to accelerate the translation of cutting-edge research into effective treatments for critical conditions such as heart failure, Parkinson's disease, and cancer. This investment underscores the vital role of cell culture technologies in advancing therapeutic innovations.
By product, the bags segment accounted for the highest revenue-grossing segment in the global cell culture vessels market in 2023 owing to the increasing adoption of single-use technologies and their advantages in scalability, cost-effectiveness, and reduced contamination risks. For instance, in September 2023, Defined Bioscience, Inc. formed a collaboration with Cell Culture Collective, Inc. to commercialize its serum-free stem cell culture products. Cell Culture Collective will be an authorized distributor of Defined Bioscience's optimized animal/serum-free stem cell culture products under the terms of this agreement. Additionally, the flasks segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing demand for cell-based research, ease of use, and widespread application in academic and research laboratories.
By type, the single-use segment accounted for the highest revenue-grossing segment in the global cell culture vessels market in 2023 owing to the growing preference for disposable technologies, which offer reduced contamination risks, lower operational costs, and increased flexibility in biomanufacturing processes. For instance, in March 2024, Getinge announced the introduction of a revolutionary SUPR system, a scalable single-use bioreactor for pilot and GMP manufacture. It has larger versions of their lab-scale bioreactors, is gamma sterilized, and takes up less space. Additionally, the reusable segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising focus on sustainability, cost savings in long-term use, and increasing demand for durable and reliable cell culture vessels in research and production.
By end-user, the pharmaceutical & biotechnology companies segment accounted for the highest revenue-grossing segment in the global cell culture vessels market in 2023 owing to the increased demand for biologics, cell-based therapies, and vaccine production, as well as ongoing research and development efforts. For instance, Freudenberg Medical said in August 2024 that it will expand its biopharma products to include unique single-use assemblies such as Y-connector manifolds, tubing assemblies, and multi-inlet bottle caps. These would be utilized in laboratories and CGMP bioprocesses to transport essential fluids. Additionally, the CMOs & CROs segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising outsourcing of drug development, increased focus on cost-efficiency, and growing demand for specialized services in biopharmaceutical research and production.
North American region is anticipated for the highest revenue share during the forecast period owing to the strong presence of key biopharmaceutical companies, advanced research infrastructure, and increased investment in biotechnology and life sciences. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to increasing investments in biotechnology, a growing pharmaceutical industry, and the rising demand for biopharmaceuticals and cell-based research in emerging economies. For instance, in April 2024, Fujifilm Corporation announced a USD1.2 billion investment to develop its cell culture CDMO business and increased its investment in the Fujifilm Diosynth Biotechnologies plant in Holly Springs, North Carolina, to more than USD 3.2 billion.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Governments and private sectors are significantly increasing investments in life sciences research, including cell and molecular biology, driving the growing demand for cell culture vessels. For instance, the Novo Nordisk Foundation, in September 2023, committed approximately USD 141.29 million to establish a state-of-the-art facility dedicated to developing and scaling cell therapies. This facility aims to accelerate the translation of cutting-edge research into effective treatments for critical conditions such as heart failure, Parkinson's disease, and cancer. This investment underscores the vital role of cell culture technologies in advancing therapeutic innovations.
By product, the bags segment accounted for the highest revenue-grossing segment in the global cell culture vessels market in 2023 owing to the increasing adoption of single-use technologies and their advantages in scalability, cost-effectiveness, and reduced contamination risks. For instance, in September 2023, Defined Bioscience, Inc. formed a collaboration with Cell Culture Collective, Inc. to commercialize its serum-free stem cell culture products. Cell Culture Collective will be an authorized distributor of Defined Bioscience's optimized animal/serum-free stem cell culture products under the terms of this agreement. Additionally, the flasks segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing demand for cell-based research, ease of use, and widespread application in academic and research laboratories.
By type, the single-use segment accounted for the highest revenue-grossing segment in the global cell culture vessels market in 2023 owing to the growing preference for disposable technologies, which offer reduced contamination risks, lower operational costs, and increased flexibility in biomanufacturing processes. For instance, in March 2024, Getinge announced the introduction of a revolutionary SUPR system, a scalable single-use bioreactor for pilot and GMP manufacture. It has larger versions of their lab-scale bioreactors, is gamma sterilized, and takes up less space. Additionally, the reusable segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising focus on sustainability, cost savings in long-term use, and increasing demand for durable and reliable cell culture vessels in research and production.
By end-user, the pharmaceutical & biotechnology companies segment accounted for the highest revenue-grossing segment in the global cell culture vessels market in 2023 owing to the increased demand for biologics, cell-based therapies, and vaccine production, as well as ongoing research and development efforts. For instance, Freudenberg Medical said in August 2024 that it will expand its biopharma products to include unique single-use assemblies such as Y-connector manifolds, tubing assemblies, and multi-inlet bottle caps. These would be utilized in laboratories and CGMP bioprocesses to transport essential fluids. Additionally, the CMOs & CROs segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising outsourcing of drug development, increased focus on cost-efficiency, and growing demand for specialized services in biopharmaceutical research and production.
North American region is anticipated for the highest revenue share during the forecast period owing to the strong presence of key biopharmaceutical companies, advanced research infrastructure, and increased investment in biotechnology and life sciences. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to increasing investments in biotechnology, a growing pharmaceutical industry, and the rising demand for biopharmaceuticals and cell-based research in emerging economies. For instance, in April 2024, Fujifilm Corporation announced a USD1.2 billion investment to develop its cell culture CDMO business and increased its investment in the Fujifilm Diosynth Biotechnologies plant in Holly Springs, North Carolina, to more than USD 3.2 billion.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Product, Type, and End-User
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of the Top 10+ Major Market Players
- 20% Free Customization Available to Meet Your Exact Requirement.
Segmentation: Cell Culture Vessels Market Report 2023 - 2034
Cell Culture Vessels Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Bags
- Flasks
- T-flasks
- Spinner Flasks
- Gas Permeable Membrane Flasks
- Others
- Plates
- Bottles
- Others
Cell Culture Vessels Market Analysis & Forecast by Type 2023 - 2034 (Revenue USD Bn)
- Reusable
- Single use
Cell Culture Vessels Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Bn)
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- CMOs & CROs
Cell Culture Vessels Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Cell Culture Vessels Market: Product Estimates & Trend Analysis
8. Cell Culture Vessels Market: Type Estimates & Trend Analysis
9. Cell Culture Vessels Market: End-User Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Cell Culture Vessels Market
12. Europe Global Cell Culture Vessels Market
13. Asia Pacific Global Cell Culture Vessels Market
14. Latin America Global Cell Culture Vessels Market
15. MEA Global Cell Culture Vessels Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Thermo Fisher Scientific Inc.
- STEMCELL Technologies
- Merck KGaA
- Greiner Bio-One International GmbH
- Corning Incorporated
- Wilson Wolf
- DWK Life Sciences
- Cell Culture Company LLC
- VWR International LLC
- Danaher
- Sartorius Stedim Biotech
- Fujifilm Corporation
- Lonza Group AG
- Eppendorf AG
- Bio-Rad Laboratories Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | December 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 4.38 Billion |
| Forecasted Market Value ( USD | $ 20.09 Billion |
| Compound Annual Growth Rate | 14.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
